Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: acromegaly  treatment  chiasma  octreotide  capsules  injection  medication  medicine  growth  hormone  multivu  7436451  asuragen  fragilex  syndromes  autism  xpansion  interpreter  genetic  test  pregnancy  children  women  health  multivu  60719  research  astro  science  cancer  early  stage  breast  cancer  health  technology  advancement  doctors  multivu  7661231  wellness  prevention  health  blood  test  results  ortho  clinical  diagnostics  know  your  numbers  nacdd  patient  multivu  52662  gene  therapy  hemophilia  b  bleeding  disorder  st  jude  childrens  research  hospital  university  college  london  multivu  46766  disease  health  research  healthcare  treatment  technology  new  help  wellness  multivu  8268751  health  supplement  joint  pain  gopo  natural  plant  based  medicine  treatment  mobility  multivu  7918251  gout  management  inflammatory  arthritis  diet  uric  acid  flares  treatment  purines  ascr  multivu  56234  varian  medical  systems  halcyon  health  healthcare  cancer  treatment  imrt  multivu  8065951  hello  brushing  teeth  children  toothpastes  health  hygiene  parents  retail  multivu  7781251  hologic  genius  3d  mammography  cancer  exam  mammogram  detection  women  health  multivu  7254155  caralluma  fimbriata  for  weight  loss  clinical  study  weight  loss  lose  review  actives  burn  appetite  suppressant  buy  where  to  try  caraluma  suppress 
Search // clinical
Results 49-60 of 101 for ' clinical ' (1 seconds)
Varian Medical Systems (NYSE: VAR) today is introducing the Halcyon™ system, an entirely new device for cancer treatment. Engineered to revolutionize clinical workflow, Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT). This new treatment system is designed to expand the availability of high quality cancer care globally and help save the lives of millions more cancer patients. “The global cancer challenge is enormous,” said Kolleen Kennedy, president of Varian's Oncology Systems business. “It is expected that there will be 24.6 million cancer cases diagnosed annually by 2030, and there is an acute shortage of equipment and trained clinicians. With the innovations in this new technology platform, the system will deliver high quality Halcyon treatments that empower clinicians to care for many more patients. At Varian we are very excited with the introduction of Halcyon to be taking another big step toward advancing cost-effective cancer care worldwide.” To view the multimedia release go to: https://www.multivu.com/players/English/8065951-varian-medical-systems-halcyon-cancer-treatment/
Categories // Miscellaneous 
Added: 2733 days ago by MultiVuVideos
Runtime: 3m34s | Views: 554 | Comments: 0
Not yet rated
 

 

 

New recommendations from the American Society of Clinical Rheumatologists (ASCR), published in Postgraduate Medicine, highlight updated management recommendations for patients with acute gout. These new recommendations come at a time when the incidence of gout is soaring; 8.3 million Americans are estimated to be gout patients. Instead of challenging, restrictive dieting, patients are encouraged to consume a balanced diet of fresh fruit and vegetables, low-fat dairy products, nuts and grains. More importantly, patients should limit their intake of high fructose corn syrup, a common ingredient in many processed foods and drinks, and purine-rich foods, particularly red meat, beer and shellfish. To view Multimedia News Release, go to http://www.multivu.com/mnr/56234-gout-uric-acid-education-arthritis-lifestyle-change-treatment-options
Categories // People and Blog 
Added: 4545 days ago by MultiVuVideos
Runtime: 3m56s | Views: 4842 | Comments: 0
Not yet rated
 

 

 

TransCelerate BioPharma Inc., a non-profit organization dedicated to improving the health of people around the world by simplifying and accelerating research and development of innovative new therapies, has unveiled a new global campaign designed to help increase awareness of the growing need for clinical trial participants. The campaign, called “One Person Closer,” focuses on inspiring healthcare professionals (HCPs) to consider clinical research as a possibility for their patients, incorporate the topic into their daily practices, and have meaningful conversations with patients about opportunities to participate in clinical trials. One Person Closer is designed to put a human face on research and development by sharing the personal stories of researchers, HCPs and patients who have contributed to clinical research and the development of medical breakthroughs. The photojournalist campaign aims to show doctors, nurses and other HCPs that they can help facilitate research that advances science and that may benefit their patients. To view the multimedia release go to: https://www.multivu.com/players/English/8268751-transcelerate-biopharma-one-person-closer/
Categories // Miscellaneous 
Added: 2458 days ago by MultiVuVideos
Runtime: 1m28s | Views: 673 | Comments: 4
Not yet rated
 

 

 

Symptoms improved significantly in adults with the bleeding disorder hemophilia B following a single treatment with gene therapy developed by researchers at St. Jude Children’s Research Hospital in Memphis and demonstrated to be safe in a clinical trial conducted at the University College London (UCL) in the U.K. The findings of the six-person study mark the first proof that gene therapy can reduce disabling, painful bleeding episodes in patients with the inherited blood disorder. Results of the Phase I study appear in the December 10 online edition of the New England Journal of Medicine. The research is also scheduled to be presented December 11 at the 53rd annual meeting of the American Society of Hematology in San Diego. To view Multimedia News Release, go to http://www.multivu.com/mnr/46766-st-jude-children-s-research-hospital-gene-therapy-bleeding-disorder
Categories // Science and Technology 
Added: 4705 days ago by MultiVuVideos
Runtime: 4m58s | Views: 4234 | Comments: 0
Not yet rated
 

 

 

Ortho Clinical Diagnostics (OCD), in partnership with the National Association of Chronic Disease Directors (NACDD), today unveiled new consumer survey results and a report revealing the state of blood test health literacy in the United States with strategies to support much-needed patient education and empowerment. The first step: ensuring patient access to and understanding of blood test results, a critical component to maintaining health and wellness. The campaign kicks off during National Health Literacy Month, an awareness effort founded in 1999 to promote the importance of understandable health information. To view Multimedia News Release, go to http://www.multivu.com/mnr/52662-ortho-clinical-diagnostics-and-nacdd-blood-test-health-literacy-survey
Categories // News and Politics 
Added: 4760 days ago by MultiVuVideos
Runtime: 2m23s | Views: 5162 | Comments: 0
Not yet rated
 

 

 

Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated. Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal. “We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.” To view the multimedia release go to: http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Categories // Miscellaneous 
Added: 3292 days ago by MultiVuVideos
Runtime: 1m25s | Views: 924 | Comments: 0
Not yet rated
 

 

 

Asuragen Inc., a leading molecular diagnostics company, today announced results from a study demonstrating that a new molecular test called Xpansion Interpreter® can improve the determination of a woman’s risk of having a child with fragile X syndrome, the most common inherited cause of intellectual disability and autism, compared to existing risk measures. The Xpansion Interpreter Test is based on a technology breakthrough that reveals both the number and position of “interrupting” DNA sequences in the fragile X gene of the mother and more accurately estimates the likelihood that her child will have fragile X syndrome. The study will be published in the April issue of the American Journal of Medical Genetics and presented today at the 2013 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting in Phoenix, AZ. To view Multimedia News Release, go to http://www.multivu.com/mnr/60719-asuragen-xpansion-interpreter-xi-test-data-fragile-x-syndrome-autism
Added: 4242 days ago by MultiVuVideos
Runtime: 3m22s | Views: 1972 | Comments: 0
Not yet rated
 

 

 

Chiasma, Inc., a U.S. privately–held biopharma company developing octreotide capsules for the orphan condition acromegaly, today announced two new studies presented at the 97th Endocrine Society (ENDO) Annual Meeting in San Diego, Calif. The studies provide additional data from Chiasma’s Phase III trial and new findings on the patient burden of current injection therapies. “We now have data to help clinicians determine whether octreotide capsules, if approved, are likely to help their patient with acromegaly maintain response,” said Shlomo Melmed, M.D., senior vice president and dean, Cedars–Sinai Medical Center, Los Angeles and global study principal investigator. “Furthermore, the Phase III results show the safety and efficacy of octreotide capsules can be reliably determined within 12 weeks of initiating therapy.” To view the Multimedia News Release, go to http://www.multivu.com/players/English/7436451-endo-chiasma-clinical-data/
Added: 3527 days ago by MultiVuVideos
Runtime: 4m34s | Views: 852 | Comments: 2
Not yet rated
 

 

 

The full set of data from EUCLID, the largest ever prevalence study of Clostridium difficile infection (CDI) across Europe, were presented today at the 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Data from 482 European hospitals reveal that in a single day, an average of 109 cases of CDI are missed due to a lack of clinical suspicion or inadequate laboratory testing, potentially leading to more than 39,000 missed cases in Europe each year. To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400524-EUCLID-clostridium-difficile-infection
Categories // Science and Technology 
Added: 3825 days ago by MultiVuVideos
Runtime: 4m43s | Views: 755 | Comments: 1
Not yet rated
 

 

 

Upsher-Smith Laboratories, Inc. [http://www.upsher-smith.com] today announced that subscribers to Epilog.us can now access the latest information related to Practice Management & Epilepsy at http://www.Epilog.us. Led by Dr. Aatif Husain, Director of the Clinical Neurophysiology Fellowship, Professor of Medicine, Division of Neurology, Duke University Medical Center, and Dr. John Stern, Co‐Director of the Seizure Disorder Center and Professor of Neurology at the David Geffen School of Medicine at UCLA, areas of focus include: the importance of billing code accuracy; commonly utilized billing codes in epilepsy and neurology; and epilepsy quality measures from the American Academy of Neurology (AAN). To view Multimedia News Release, go to http://www.multivu.com/mnr/58062-upsher-smith-epilog-us-practice-management-epilepsy-resources-available
Categories // People and Blog  Business 
Added: 4432 days ago by MultiVuVideos
Runtime: 5m29s | Views: 2370 | Comments: 1
Not yet rated
 

 

 

Emdeon Inc., a leading provider of healthcare revenue and payment cycle management and clinical information exchange solutions, today announced the expansion of Emdeon Clinical Exchange™, its technology-enabled solution designed to improve business and clinical outcomes and care continuity. Emdeon Clinical Exchange encompasses products and services that are designed to unite healthcare communities. Today, hospitals, physicians, labs, payers and pharmacies use Emdeon’s leading healthcare information network to securely exchange health information over six billion times annually. These healthcare stakeholders are demanding greater connectivity to each other and the ability to facilitate comprehensive, end-to-end clinical information exchange. To view Multimedia News Release, go to http://www.multivu.com/mnr/48120-emdeon-expands-clinical-information-exchange-capabilities
Categories // Business  Science and Technology 
Added: 4448 days ago by MultiVuVideos
Runtime: 1m47s | Views: 2352 | Comments: 1
Not yet rated
 

 

 

Emdeon Inc., a leading provider of revenue and payment cycle management and clinical information exchange solutions, today announced the launch of Emdeon EDGE™, an integrated, technology-enabled solution that includes complete payment integrity and cost containment services designed to help detect improper healthcare claims and prevent inaccurate payments. To view Multimedia News Release, go to http://www.multivu.com/mnr/48121-emdeon-edge-payment-integrity-cost-management
Categories // Business 
Added: 4384 days ago by MultiVuVideos
Runtime: 1m16s | Views: 3544 | Comments: 0
Not yet rated
 

 

 

Page 5 of 9  |  Go to page     |  ««FIRST «Previous  Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2024 ClipMoon.com. All rights reserved.